198 related articles for article (PubMed ID: 1087180)
1. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
Pinedo HM; Zaharko DS; Bull JM; Chabner BA
Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
[TBL] [Abstract][Full Text] [Related]
2. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
[TBL] [Abstract][Full Text] [Related]
3. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
Strømhaug A; Warren DJ; Slørdal L
Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815
[TBL] [Abstract][Full Text] [Related]
4. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
5. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
Sobrero AF; Bertino JR
Int J Cell Cloning; 1986 Jan; 4(1):51-62. PubMed ID: 2936838
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
Rosenblatt DS; Whitehead VM; Matiaszuk NV; Pottier A; Vuchich MJ; Beaulieu D
Mol Pharmacol; 1982 May; 21(3):718-22. PubMed ID: 6180291
[TBL] [Abstract][Full Text] [Related]
7. The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.
Pinedo HM; Zaharko DS; Bull J; Chabner BA
Cancer Res; 1977 Feb; 37(2):445-50. PubMed ID: 832268
[TBL] [Abstract][Full Text] [Related]
8. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate cytotoxicity: studies on its reversal by folates and nucleosides.
Leyva A; Nederbragt H; Lankelma J; Pinedo HM
Cancer Treat Rep; 1981; 65 Suppl 1():45-50. PubMed ID: 6173122
[TBL] [Abstract][Full Text] [Related]
10. Resistance of human bone marrow CFUC to high-dose methotrexate cytotoxicity.
Koizumi S; Yamagami M; Ueno Y; Miura M; Taniguchi N
Exp Hematol; 1980 May; 8(5):635-40. PubMed ID: 7461061
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Cole PD; Smith AK; Kamen BA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
[TBL] [Abstract][Full Text] [Related]
12. Reversal of methotrexate cytotoxicity to human bone marrow cells and leukemic K562 cells by leucovorin: methotrexate polyglutamates formation as a possible important factor.
Koizumi S; Ueno Y; Ohno I; Ichihara T; Tamaru Y; Matsukawa H
Jpn J Cancer Res; 1990 Nov; 81(11):1162-7. PubMed ID: 1702414
[TBL] [Abstract][Full Text] [Related]
13. 7-Hydroxymethotrexate cytotoxicity and selectivity in a human Burkitt's lymphoma cell line versus human granulocytic progenitor cells: rescue by folinic acid and nucleosides.
Fabre I; Fabre G; Cano JP
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1247-54. PubMed ID: 3493143
[TBL] [Abstract][Full Text] [Related]
14. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
15. [Effect of rescue treatment with high doses of methotrexate (MTX) followed by leucovorin (LV) on neoplastic cells (HeLa line) and normal sensitized peripheral lymphocytes].
Ruano A; Alvarez-Rodríguez Y; Valladares Y
Rev Esp Oncol; 1982; 29(4):665-73. PubMed ID: 6985426
[TBL] [Abstract][Full Text] [Related]
16. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Samuels LL; Straw JA
Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
Taylor IW; Tattersall MH
Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
[TBL] [Abstract][Full Text] [Related]
18. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.
Howell SB; Krishan A; Frei E
Cancer Res; 1979 Apr; 39(4):1315-20. PubMed ID: 311245
[TBL] [Abstract][Full Text] [Related]
19. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.
Fabre I; Fabre G; Goldman ID
Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743
[TBL] [Abstract][Full Text] [Related]
20. Long-term bone marrow culture as a model for host toxicity: the effect of methotrexate on hematopoiesis and adherent layer function.
Williams LH; Udupa KB; Lipschitz DA
Exp Hematol; 1988 Jan; 16(1):80-7. PubMed ID: 3257191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
